Your meeting is confirmed!

If you would like to change your scheduled time slot, please use the confirmation email you received.

Looking forward to seeing you!

Your meeting is confirmed!

If you would like to change your scheduled time slot, please use the confirmation email you received.

Looking forward to seeing you!

Here is a free whitepaper:

“Five Reasons
to Outsource API Procurement”

Whitepaper Sample
VIP Icon

VIP Access
to API Manufacturers

Supplier Icon

Introductions
to
Suppliers

Supply Chain Icon

Supply Chain
at
Hyperspeed!

Compliant Icon

You’ll be compliant. Always.

Insights Icon

Insights & Connections
For your future

Enter the information below to begin the download:

“Five Reasons
to Outsource API Procurement”

Whitepaper Sample

Enter the information below to begin the download:

Here is a free whitepaper:

“Five Reasons
to Outsource API Procurement”

Whitepaper Sample

Enter your information below
to begin the download:

LGM Pharma's Featured Client Focus - Drug Delivery Technologies:

InSitu

InSitu Biologics develops implantable time release products composed of its proprietary tunable, bio-polymeric hydrogel, Matrix™. Implantable, tunable compounds similar to their Matrix are gaining attention in biomedical applications targeting tissue and nerves.

Orbis Biosciences, Inc. provides controlled-release delivery technologies to create revolutionary pharmaceutical products that are safer and more effective than existing treatment options.

opertech-bio

Opertech Bio is a service-based business offering its customers a pioneering approach to measuring taste, covering the food and beverage, flavor ingredients, pet food, and pharmaceutical industries.

Illustris is a clinical-stage biodevelopment company whose objective is to reduce society’s exposure to potentially harmful active agents by utilizing novel permeation technology to deliver active agents through tissue structures more efficiently.

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service